Core Viewpoint - The recent public fund reports reveal that high-performing funds have achieved impressive returns by focusing on sectors like innovative pharmaceuticals and new consumption, while also highlighting a trend towards thematic funds targeting niche markets [1][2][5]. Fund Performance and Holdings - High-performing funds have seen significant returns, with the Changcheng Pharmaceutical Industry Fund achieving a return rate of 102.52% this year, driven primarily by its focus on innovative pharmaceuticals [2]. - Many top-performing funds in the first half of the year are pharmaceutical-themed, including Zhongyin Hong Kong Stock Connect Pharmaceutical and Huashan Pharmaceutical Biotechnology [2][3]. - The top holdings of several funds have shifted towards technology and pharmaceuticals, with notable new additions like Zhongji Xuchuang and Xin Yisheng in the top ten holdings of the China Europe Digital Economy Mixed Fund [3]. Thematic Funds and Sector Focus - Some actively managed funds have undergone significant portfolio changes, with a complete overhaul of their top holdings to focus on emerging sectors like robotics and short dramas [4]. - The Tongtai Industry Upgrade Mixed Fund increased its stock position from 30% to 90% and shifted its focus to robotics, while the Tongtai Huile Mixed Fund transitioned to short drama and gaming stocks [4]. - Fund companies are launching numerous thematic products targeting specific high-growth sectors, such as controllable nuclear fusion and deep-sea technology, indicating a trend towards specialized investment strategies [5]. Market Outlook - Fund managers maintain a positive outlook for the equity market in the third quarter, with confidence in the performance of related sectors [6]. - The Changcheng Pharmaceutical Industry Fund manager anticipates growth in innovative pharmaceuticals driven by overseas licensing and domestic sales, while the Tongtai Industry Upgrade Fund manager expects significant opportunities in the robotics sector due to increased production and technological advancements [6].

随着投资热度的提升，更多的科技主题基金扎堆进入新发序列，且多只采用发起式的形式。较低的成立 门槛使这类新基金得以更快入市，比如国投瑞银中证港股通科技指数发起、鑫元创业AI指数发起式 等。 从近期机构调研来看，机构正在加速掘金AI产业链公司。以新易盛为例，该公司7月16日接待调研机构 近180家，包括易方达基金、鹏华基金、广发基金、华安基金等。该公司近日预计上半年的归母净利润 同比增幅上限高达385.47%，此次机构聚焦于公司业绩、扩产计划等方面。仕佳光子、东山精密等多家 公司近期均接受了机构的调研。 对于下半年AI的投资机会，永赢科技智选基金经理任桀表示，从产业链角度观察，中国厂商擅长的光 通信、PCB领域过去两年实现了高增长，今年以来客户逐渐提出更高、更长期的需求后，一些厂商进入 扩产阶段。随着全球大客户需求持续扩张，以及AI产业的长期发展，中国厂商有望持续分享全球AI发 展的红利。 科技主题ETF也联袂上涨，并获得大量资金的流入。数据显示，多只ETF近一个月涨幅超15%，如南方 创业板人工智能ETF、富国中证通信设备主题ETF等。相关ETF同期净申购份额较多，华夏上证科创板 50成份ETF获净申购54亿份 ...

关于武汉长盈通光电技术股份有限公司 发行股份及支付现金购买资产申请的 审核问询函的回复 独立财务顾问 二〇二五年七月 上海证券交易所： 按照贵所下发的《关于武汉长盈通光电技术股份有限公司发行股份及支付现 金购买资产申请的审核问询函》（上证科审（并购重组）〔2025〕15 号）（以 下简称"审核问询函"）的要求，武汉长盈通光电技术股份有限公司（以下简称 "公司"、"上市公司"或"长盈通"）及相关中介机构就审核问询函所提问题 进行了认真讨论分析，并按照要求在《武汉长盈通光电技术股份有限公司发行股 份及支付现金购买资产报告书（草案）》（以下简称"重组报告书"）中进行了 补充披露，现将相关回复说明如下。 如无特别说明，本审核问询函回复（以下简称"本回复"）所述的词语或简 称与重组报告书中"释义"所定义的词语或简称具有相同的含义。在本回复中， 若合计数与各分项数值相加之和在尾数上存在差异，均为四舍五入所致。本回复 所引用的财务数据和财务指标，如无特殊说明，指合并报表口径的财务数据和根 据该类财务数据计算的财务指标。 审核问询函所列问题 黑体（加粗） 审核问询函所列问题的回复、对重组报告 宋体 书的引用 对重组报告书的修 ...

Market Overview - The market opened low but rose throughout the day, with the ChiNext Index leading the gains. AI hardware stocks surged again, with companies like Mankun Technology and Cambridge Technology hitting the daily limit. Innovative drug concepts continued to strengthen, with Chengdu XianDao and Seli Medical also reaching the limit. The robotics sector was active, with companies like Aowei New Materials and Nanjing Julong hitting the limit. The military industry saw a midday rally, with companies like AVIC Shenfei and Construction Industry also reaching the limit. Overall, more than 3,500 stocks in the Shanghai and Shenzhen markets were in the green, with a total transaction volume of 1.56 trillion yuan [1]. Hotspots of the Day PCB Sector - The PCB sector experienced a significant rise, with stocks like Guanghe Technology, Mankun Technology, and Dongshan Precision hitting the daily limit. Shenghong Technology surged by 9%, reaching a new historical high. The market structure is improving due to demand driven by AI servers, high-speed networks, and satellite communications, with high-layer boards (18 layers) and HDI markets expected to grow rapidly [3][4]. Pharmaceutical Sector - The pharmaceutical sector continued to perform well, with Lisheng Pharmaceutical achieving three consecutive limits, and Asia-Pacific Pharmaceutical and Weikang Pharmaceutical also hitting the limit. The initiation of the national drug procurement work has been completed, which is expected to impact the market positively [5][6][7]. Artificial Intelligence - The AI application sector showed strong performance, with stocks like Zhiwei Intelligent hitting the limit and Jinxi Modern rising by 20%. Huang Renxun mentioned that the next wave of AI will be Physical AI, indicating a shift towards robots with perception, reasoning, and physical interaction capabilities, which will drive the next industrial wave [8][10]. Key Stock Performances - Notable stock performances included: - Mankun Technology: 20.01% increase, market cap of 1.835 billion yuan [4] - Chengdu XianDao: 20.02% increase, market cap of 8.599 billion yuan [6] - Guanghe Technology: 10.00% increase, market cap of 9.969 billion yuan [4] - Dongshan Precision: 10.00% increase, market cap of 76.677 billion yuan [4] Future Outlook - The PCB market is expected to see structural improvements driven by AI and related technologies, with growth rates projected at 40.3% for high-layer boards and 18.8% for HDI by 2025. The innovative drug sector is also entering a structural revaluation phase, with Chinese biotech companies currently valued at only 14%-15% of their US counterparts, despite contributing nearly 33% to global innovation [4][7].

今日（7月17日）光模块三剑客"易中天"继续狂飙，新易盛涨超8%，中际旭创涨逾4%，天孚通信涨超 3%，热门ETF方面，硬科技宽基——双创龙头ETF（588330）场内价格盘中涨超1．5%，现涨1． 36%。 消息面上，首先英伟达于7月16日宣布获得许可向中国交付H20 GPU；其次AMD在同日宣布获准恢复向 中国销售AI芯片；此外有头部AI服务器企业人士透露，正在急迫下单抢购H20芯片。 上述消息对CPO板块构成实质性利好。英伟达和AMD恢复对华AI芯片供应将直接拉动国内数据中心建 设需求，而CPO作为光模块先进封装技术，是800G/1.6T高速光模块的核心环节。订单急迫性反映出AI 算力基础设施的旺盛需求，产业链相关企业的业绩增长确定性显著提升。 业内人士指出，"光模块"是英伟达H20芯片的核心模块之一，随着H20芯片供应恢复，直接利好光模块 三剑客"易中天"： 1、新易盛：英伟达 800G LPO光模块供应商，H20芯片的推理算力需求将带动低功耗光模块的采购。 2、中际旭创：英伟达1.6T/800G光模块核心供应商，H20芯片的恢复供应将带动国内AI服务器需求增 长，进而提升高速光模块（尤其是800G/ ...

Group 1 - The National Communication Index has risen strongly by 1.85%, with key stocks such as Changfei Optical Fiber and Cambridge Technology hitting the daily limit, and Shijia Photon increasing by 8.59% [1] - The Communication ETF (159695) has increased by 1.92%, and over the past week, it has accumulated a rise of 4.23% [1] - The trading volume of the Communication ETF was 12.0158 million yuan, with a turnover rate of 10.86%, indicating active market trading [4] Group 2 - The Communication ETF has seen a significant growth in scale, increasing by 13.6845 million yuan over the past week, ranking first among comparable funds [4] - The ETF's net value has risen by 32.51% over the past year, with the highest single-month return reaching 24.48% since its inception [4] - The Light Counting report indicates that the optical module market in Q2 2025 is primarily driven by 800G modules, with data center optical device market revenue expected to exceed $16 billion, a year-on-year increase of over 60% [4] Group 3 - The AI sector is moving towards a "productivity reconstruction" phase, necessitating domestic substitution in computing power, while the communication industry transitions from "connectivity empowerment" to "intelligent driving" [5] - The top ten weighted stocks in the National Communication Index account for 59.17% of the index, with major players including Zhongji Xuchuang, China Telecom, and China Mobile [5] - The satellite constellation is entering a normalized launch phase, and the integration of 6G with NTN networks is deepening [5]

Core Viewpoint - The "anti-involution" theme has gained significant attention in the A-share market, with various sectors such as steel, photovoltaic, and building materials experiencing substantial growth due to policy-driven changes aimed at reducing disorderly competition [3][5][10]. Market Performance - As of July 17, A-shares opened lower but quickly turned positive, with the ChiNext Index rising over 1%, led by sectors like innovative drugs, PCB, consumer goods, and photovoltaics [1]. - In the past month, the photovoltaic equipment index increased by 15.55%, while the overall market saw nearly 3,000 stocks rise [7][9]. Sector Analysis - The "anti-involution" theme has led to significant gains in various sectors, with the steel, building materials, and electric equipment industries seeing increases of over 8% in the last 18 trading days [2]. - Key indices reflecting this trend include the circuit board index up by 3.74%, and the glass fiber index up by 20.21% [2][9]. Policy Impact - The Central Financial Committee's meeting on July 1 emphasized the need to build a unified national market and regulate low-price competition, which is expected to guide the "anti-involution" policy across key industries [5][10]. - The current phase of the "anti-involution" market is characterized as a policy-driven expectation stage, with potential for further development depending on the implementation of policies and capacity clearance [3][18]. Investment Opportunities - Investment firms are increasingly focusing on sectors involved in the "anti-involution" theme, particularly those with historically low valuations and significant potential for recovery [12][13]. - Key sectors identified for investment include traditional industries like steel and cement, as well as emerging sectors such as photovoltaics and new energy vehicles [10][16]. Future Outlook - Analysts suggest that the "anti-involution" market could evolve through three stages: initial policy-driven expectations, followed by resource price increases, and finally, sustained high prices [3][18]. - The current market is still in the expectation phase, and future developments will depend on the effectiveness of policy implementation and the recovery of corporate profits [18].

Group 1 - The core viewpoint of the articles indicates that several high-performing public funds are actively adjusting their portfolios to capture structural opportunities in the market, particularly focusing on the technology and pharmaceutical sectors, reflecting an optimistic outlook for the second half of the year [1][3] - As of July 16, among the disclosed second-quarter reports, many top-performing funds have increased their stock investment ratios, with notable examples including the Changcheng Pharmaceutical Industry Selected Mixed Fund, which raised its stock investment ratio from 72.48% to 75.89%, and the Tongtai Industrial Upgrade Mixed A Fund, which increased its stock investment ratio from 1.62% to 90.16% [1] - The holding structure shows that technology and pharmaceuticals are the main targets for fund managers' adjustments, with funds like Yongying Technology Smart Mixed A shifting focus to global cloud computing and increasing positions in leading companies in optical communication [1][3] Group 2 - Analysts express confidence in the overall performance of the equity market, with many top funds maintaining high positions based on positive assessments of relevant sectors, particularly in structural market conditions where active equity funds can leverage their stock-picking advantages [3] - Fund managers are optimistic about the third quarter, with specific focus areas including the development of innovative drugs in overseas licensing and domestic sales, as well as investment opportunities in cutting-edge models and emerging applications in the technology sector [3] - The proactive adjustments and increased allocations by high-performing funds in the second quarter reflect a long-term positive outlook on high-growth sectors like technology and pharmaceuticals, signaling potential structural opportunities in the equity market for the latter half of the year [3]

Group 1 - The core viewpoint of the article highlights that Zhongji Xuchuang expects continued growth in customer demand in the second half of the year, driven by factors such as increased demand for 1.6T products, higher recognition of silicon photonics solutions, and improved production efficiency [1] - In Q2, the company experienced significant revenue growth due to rapid demand for 800G and 400G optical modules from key customers [1] - The company is actively expanding production capacity and collaborating with optical chip manufacturers to ensure supply [1] Group 2 - The competitive advantage of silicon photonics solutions is expected to become more apparent in the future [1] - The shipment of 1.6T products is anticipated to increase significantly, with expectations of quarter-on-quarter growth [1] - The recent tariff exemption policy introduced in April has had a minimal impact on the company [1] Group 3 - The number of customers for 800G products is increasing, with new overseas customers making substantial capital expenditures [1] - There is a notable increase in demand for 1.6T products, with some customers raising their demand guidance for the second half of this year and next year [1] - The current demand is primarily for single-mode applications, with fewer multi-mode applications, catering to various scenarios including LPO, OC, and active copper cables [1]

本报记者 彭衍菘 二季度公募基金调仓图谱揭开面纱，多只业绩领跑的权益类基金操作路径逐渐清晰。记者梳理发现，截至7月16日，已披 露二季报的公募基金中，有多只绩优基金提升了权益资产仓位，通过大规模调仓换股捕捉结构性机会，其中科技与医药板块成 为核心配置方向。 多只绩优基金 提升权益资产仓位 二季度A股市场整体回暖，部分绩优基金凭借精准布局实现业绩与规模双升。长城医药产业精选混合发起式摘得公募基金 上半年净值增长率的"季军"，达75.18%，同时以9.3倍的规模增幅领跑，该基金资产净值从一季度末的1975万元飙升至二季度末 的2.04亿元。该基金二季度末投资股票市值占基金资产净值比例（以下简称"股票投资占比"）达75.89%，较一季度末的 72.48%，提升约3.4个百分点。 类似提升权益资产仓位的操作并非个例。同泰产业升级混合A股票投资占比从一季度末的1.62%提升至二季度末的 90.16%；同泰远见混合A则将股票投资占比从一季度末的78.65%提升至二季度末的85.74%。 从持仓结构看，多位绩优产品基金经理的调仓操作，集中指向科技与医药两大板块。 今年二季度，永赢科技智选混合发起A基金经理任桀将投资重心从" ...